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Introduction
Pediatric mastocytosis has generally a benign prognosis.
However some patients suffer from severe mast cell (MC)
mediator-associated symptoms including anaphylaxis.
Aim
The aim of this study was to identify predictors for MC
mediator release symptoms in children with mastocytosis.
Methods
A total of 25 children (median age of onset 14,2 months
(range, 0 mth–12ys) diagnosed with mastocytosis have
been studied. Patients were classified according to the
type of skin lesions following the WHO classification.
Mastocytosis-related symptoms and data on specific
triggering factors were systematically recorded for
3 years after diagnosis. Severity was graded according to
standard recommendations. Serum baseline total tryp-
tase (sbT) levels (CAP;Phadia Diagnostics) were mea-
sured at the time of referral. The extent of cutaneous
disease was determined using the technique used to
assess burns and is given as percentage of total body
surface area (BSA).
Results
The different subtypes of mastocytosis observed
included MPCM in 17/25(68%), MC in 4/25(16%), DCM
in 1/25(4%), and ISM in 3/25(12%) cases. Skin rubbing
and hot bath were the most common triggers for MC-
related symptoms. Other clinically relevant triggers were
irritability and fever, whereas drugs, food, perioperative
and vaccination were rarely involved. The most frequent
symptoms were flushing (68%), diarrhea (24%), and ana-
phylactic reactions (36%). Four children (1 DCM, 2 ISM,
1 MPCM) had grade 4 symptoms. The median sbT for
the whole group was 6 ng/dl (range, 2–378ng/dl). A signi-
ficantly higher (p<0.029) median sbT was found in cases
with systemic symptoms vs those without (mean rank
14.97 vs 7.93ng/dl; range, 4–378 vs 2–9.1ng/dl) and espe-
cially among patients with grade 4 symptoms (p<0.07).
BSA was significantly higher (p<0.019) in patients with
grade 4 symptoms. In line with these findings, the correla-
tion of BSA to sbT levels was significant (p<0.046).
Conclusions
Extensive cutaneous disease and higher sbT levels at dis-
ease onset can identify children at risk for severe MC
mediator release symptoms. Consequently, early antime-
diator therapy should probably be given to these children.
Published: 28 February 2014
doi:10.1186/2045-7022-4-S1-P34
Cite this article as: Chatzipetrou et al.: PD34 - Childhood mastocytosis:
serum baseline total tryptase levels and extent of cutaneous disease as
predictors of mast cell mediator release symptoms. Clinical and
Translational Allergy 2014 4(Suppl 1):P34.
2nd Department of Dermatology and Venereology, Attikon University
Hospital, Athens, Greece
Chatzipetrou et al. Clinical and Translational Allergy 2014, 4(Suppl 1):P34
http://www.ctajournal.com/content/4/S1/P34
© 2014 Chatzipetrou et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
